(Q72228246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

G D Lewis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

I Figari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

B Fendly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

W L Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

P Carter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

C Gorman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

H M Shepard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

255-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

25 October 2019

cites work

1 reference

12 December 2020

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

12 December 2020

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

12 December 2020

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

12 December 2020

myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines

1 reference

12 December 2020

Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth

1 reference

12 December 2020

Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line

1 reference

12 December 2020

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

12 December 2020

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

1 reference

12 December 2020

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer

1 reference

12 December 2020

p185neu expression in human lung adenocarcinomas predicts shortened survival

1 reference

12 December 2020

Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.

1 reference

12 December 2020

Human immune response to multiple injections of murine monoclonal IgG.

1 reference

12 December 2020

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

12 December 2020

Oncogene alterations in endometrial carcinoma

1 reference

12 December 2020

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

12 December 2020

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

1 reference

12 December 2020

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Expression of cellular oncogenes in human malignancies

1 reference

12 December 2020

The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor

1 reference

12 December 2020

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

1 reference

12 December 2020

Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer

1 reference

12 December 2020

Overexpression of the c-erbB-2 protein in human breast tumor cell lines

1 reference

12 December 2020

Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification

1 reference

12 December 2020

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

1 reference

12 December 2020

Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer

1 reference

12 December 2020

ras Oncogenes and the molecular mechanisms of carcinogenesis.

1 reference

12 December 2020

Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue

1 reference

12 December 2020

The significance of oncogene amplification in primary breast cancer

1 reference

12 December 2020

High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines.

1 reference

12 December 2020

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene

1 reference

12 December 2020

Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

1 reference

12 December 2020

Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes.

1 reference

12 December 2020

Amplification and expression of the c-myc oncogene in human lung cancer cell lines

1 reference

12 December 2020

Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues

1 reference

12 December 2020

Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors

1 reference

12 December 2020

Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers

1 reference

12 December 2020

Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo

1 reference

12 December 2020

Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells

1 reference

12 December 2020

Cytogenetics and DNA amplification in colorectal cancers

1 reference

12 December 2020

In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast Tumors

1 reference

12 December 2020

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

12 December 2020

Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma

1 reference

12 December 2020

Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo

1 reference

12 December 2020

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

1 reference

12 December 2020

Expression of c-erbB-2 in Human Pancreatic Adenocarcinomas

1 reference

12 December 2020

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

1 reference

12 December 2020

Epidermal growth factor receptors in human breast cancer

1 reference

12 December 2020

Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.

1 reference

12 December 2020

Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product

1 reference

12 December 2020

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

12 December 2020

Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

1 reference

12 December 2020

Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis

1 reference

12 December 2020

Amplification of a novel v-erbB-related gene in a human mammary carcinoma

1 reference

12 December 2020

Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy

1 reference

12 December 2020

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells

1 reference

12 December 2020

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

12 December 2020

Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action

1 reference

12 December 2020

ELISA for quantitation of the extracellular domain of p185HER2 in biological fluids

1 reference

12 December 2020

Expression of c-erbB-2 gene product in urinary bladder cancer

1 reference

12 December 2020

Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance

1 reference

12 December 2020

1 reference

12 December 2020

Expression and amplification of the N-myc gene in primary retinoblastoma

1 reference

12 December 2020

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer

1 reference

12 December 2020

Reshaping human antibodies for therapy

1 reference

12 December 2020

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

1 reference

12 December 2020

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

12 December 2020

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01518520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8102322%20AND%20SRC:MED&resulttype=core&format=json